Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1140602

	registered interest
	date	19/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 19 July 2019 to Question 273399 on HIV Infection: Salford, if he will take steps to ensure that gay and bisexual men in Salford have access to PrEP.
	tabling member constituency	Salford and Eccles
	tabling member printed	Rebecca Long Bailey
	uin	279454
	answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>The pre-exposure prophylaxis (PrEP) Impact Trial is managed by the Trial Sponsor. Recruitment to places in the Trial is managed locally by participating clinics. Following funding from NHS England to pay for extra PrEP drug and research costs and the my Rt. hon Friend the Secretary of State for Health and Social Care’s announcement on 30 January that the number of places on the PrEP Impact Trial would be doubled to 26,000, expansion of the Trial is now underway across the country. Participation in the Trial is on a voluntary basis and it is for research clinics and local authorities to decide whether they wish to take part and the number of allocated places they can accept.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 12:17:05 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4396 label Biography information for Rebecca Long Bailey

1137738

	registered interest
	date	09/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Insomnia: Melatonin
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reasons Circadin is available in Scotland for the treatment of insomnia caused as a result of dementia but not in England.
	tabling member constituency	Salford and Eccles
	tabling member printed	Rebecca Long Bailey
	uin	275216
	answer	answer is ministerial correction date of answer 16/07/2019 answer text <p>The availability of treatments in Scotland is a matter for the devolved administration.</p><p>In England, the National Institute for Health and Care Excellence (NICE) is the independent body that develops authoritative, evidence-based guidance on best practice in health and social care. NICE’s guideline on the assessment, management and support for people living with dementia and their carers, published in 2018, recommends that Circadin (melatonin) should not be offered to manage insomnia in people living with Alzheimer's disease, and that a personalised multicomponent sleep management approach that includes sleep hygiene education, exposure to daylight, exercise and personalised activities should be considered for people living with dementia who have sleep problems.</p><p>Further information about the evidence underpinning NICE’s guideline is available at the following link:</p><p><a href="https://www.nice.org.uk/guidance/ng97/evidence/full-guideline-pdf-4852695709" target="_blank">https://www.nice.org.uk/guidance/ng97/evidence/full-guideline-pdf-4852695709</a></p><p>NICE does not make recommendations on the use of melatonin in the treatment of patients living with other types of dementia who have sleep problems.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 275217 question first answered 16/07/2019 14:42:57 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4396 label Biography information for Rebecca Long Bailey

1137739

	registered interest
	date	09/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Insomnia: Melatonin
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to make Circadin available in England to people suffering from insomnia caused by dementia.
	tabling member constituency	Salford and Eccles
	tabling member printed	Rebecca Long Bailey
	uin	275217
	answer	answer is ministerial correction date of answer 16/07/2019 answer text <p>The availability of treatments in Scotland is a matter for the devolved administration.</p><p>In England, the National Institute for Health and Care Excellence (NICE) is the independent body that develops authoritative, evidence-based guidance on best practice in health and social care. NICE’s guideline on the assessment, management and support for people living with dementia and their carers, published in 2018, recommends that Circadin (melatonin) should not be offered to manage insomnia in people living with Alzheimer's disease, and that a personalised multicomponent sleep management approach that includes sleep hygiene education, exposure to daylight, exercise and personalised activities should be considered for people living with dementia who have sleep problems.</p><p>Further information about the evidence underpinning NICE’s guideline is available at the following link:</p><p><a href="https://www.nice.org.uk/guidance/ng97/evidence/full-guideline-pdf-4852695709" target="_blank">https://www.nice.org.uk/guidance/ng97/evidence/full-guideline-pdf-4852695709</a></p><p>NICE does not make recommendations on the use of melatonin in the treatment of patients living with other types of dementia who have sleep problems.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 275216 question first answered 16/07/2019 14:42:57 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4396 label Biography information for Rebecca Long Bailey

1137060

	registered interest
	date	04/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reasons SHINE sexual health services at Salford are not open for gay and bisexual men on the PrEP impact trial.
	tabling member constituency	Salford and Eccles
	tabling member printed	Rebecca Long Bailey
	uin	273398
	answer	answer is ministerial correction date of answer 12/07/2019 answer text <p>Information on the reasons why SHINE sexual health services are not open for gay and bisexual men on the pre-exposure prophylaxis (PrEP) impact trial is not collected centrally.</p><p>PrEP is provided by the National Health Service through the three year PrEP Impact Trial. Participation in the trial is on a voluntary basis and it is for clinics and local authorities to decide whether they wish to take part.</p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 273399 question first answered 12/07/2019 10:18:37 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4396 label Biography information for Rebecca Long Bailey

1137062

	registered interest
	date	04/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that gay and bisexual men accessing the SHINE clinic in Salford have access to PrEP.
	tabling member constituency	Salford and Eccles
	tabling member printed	Rebecca Long Bailey
	uin	273399
	answer	answer is ministerial correction date of answer 12/07/2019 answer text <p>Information on the reasons why SHINE sexual health services are not open for gay and bisexual men on the pre-exposure prophylaxis (PrEP) impact trial is not collected centrally.</p><p>PrEP is provided by the National Health Service through the three year PrEP Impact Trial. Participation in the trial is on a voluntary basis and it is for clinics and local authorities to decide whether they wish to take part.</p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 273398 question first answered 12/07/2019 10:18:37 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4396 label Biography information for Rebecca Long Bailey